CRYOPORT, INC. Other Current Assets
CRYOPORT, INC. (CYRX) had Other Current Assets of $288.96 thousand as of 2015-12-31, per its 10-Q filed 2016-02-11.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2016-02-11
- 2015-12-31: Other Assets, Current $288.96K.
- 2015-09-30: Other Assets, Current $188.67K.
- 2015-06-30: Other Assets, Current $263.23K.
- 2015-03-31: Other Assets, Current $97.34K.
| Period end | Other Assets, Current |
|---|---|
| 2015-12-31 | $288.96K 10-Q · filed 2016-02-11 |
| 2015-09-30 | $188.67K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $263.23K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $97.34K 10-Q · filed 2016-02-11 |
| 2014-12-31 | $122.41K 10-Q · filed 2015-02-05 |
| 2014-09-30 | $85.31K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $81.42K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $196.50K 10-K · filed 2015-05-19 |
| 2013-12-31 | $102.72K 10-Q · filed 2014-02-13 |
| 2013-09-30 | $40.69K 10-Q · filed 2013-11-18 |
| 2013-06-30 | $185.01K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $138.89K 10-K · filed 2014-06-25 |
| 2012-12-31 | $57.03K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $38.63K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $37.59K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $65.97K 10-K · filed 2013-06-25 |
| 2011-12-31 | $134.64K 10-Q · filed 2012-02-21 |
| 2011-09-30 | $251.32K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $387.90K 10-Q · filed 2011-08-15 |
| 2011-03-31 | $528.04K 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |